Board of Overseers
Board of Overseers members help us reach others who understand and appreciate the impact of chemistry, chemical engineering, and the life sciences on society.
Fred Aftalion
Fondation de la Maison de la Chimie
Ivan Amato
Author
John J. (Jack) Baldwin
Vitae Pharmaceuticals
Sol J. Barer
Celgene
Jacqueline K. Barton
California Institute of Technology
Rudy M. Baum
Chemical and Engineering News
James C. Blair
Domain Associates
Joshua S. Boger
Vertex Pharmaceuticals
Brook Byers
Kleiner Perkins Caufield & Byers
Mark J. Cardillo
Camille and Henry Dreyfus Foundation
Robert J. Carpenter
Hydra Biosciences
Marc N. Casper
Thermo Fisher Scientific
Pat N. Confalone
Confalone Consulting, LLC
Susan Desmond-Hellmann
Bill & Melinda Gates Foundation
Roy T. Eddleman*
Spectrum LifeSciences
Lawrence B. Evans
Rive Technology
Robert E. Finnigan
Finnigan Corporation
Jay T. Flatley
Illumina
Marye Anne Fox
University of California, San Diego
Christopher N. Garabedian
Xontogeny
James M. Gentile
Research Corporation
Dennis B. Gillings
GHO Capital
Alan D. Gold
BioMed Realty
Joseph L. Goldstein
UT Southwestern Medical Center
Harry B. Gray
Beckman Institute, California Institute of Technology
James C. Greenwood
Biotechnology Innovation Organization
Robert H. Grubbs
California Institute of Technology
Harry E. Gruber
Tocagen
Rajiv L. Gupta
Avantor Performance Materials
David W. Haas
The William Penn Foundation
Bruce J. Hach
Hach Scientific Foundation
David F. Hale
Hale BioPharma Ventures
William A. Haseltine
ACCESS Health International
Dudley R. Herschbach
Harvard University
Roald Hoffmann
Cornell University
Sally Smith Hughes
University of California, Berkeley
Perry Karsen
Celgene
Rachel K. King
GlycoMimetics, Inc.
Robert S. Langer
Massachusetts Institute of Technology
Thomas B. Lewis
Chiral Technologies, retired
Gregory T. Lucier
NuVasive
Maria L. Maccecchini
QR Pharma Inc.
Magda Marquet
Ajinomoto Althea, Inc.
Carver A. Mead
California Institute of Technology
Joseph A. Miller, Jr.
Corning Corporation, retired
Gordon E. Moore
Intel Corporation
Scott W. Morrison
Ernst & Young, retired
Tina S. Nova
Molecular Stethoscope
Mary Jo Nye
Oregon State University
Michael H. Ott
Polysciences, Inc.
Stelios Papadopoulos
Biogen
Rudolph Pariser
DuPont
Adelene Perkins
Infinity Pharmaceuticals
Cecil B. Pickett
Zimmer Holdings, Inc.
Richard F. Pops
Alkermes
George Poste
Arizona State University
Dennis J. Purcell
Aisling Capital
Edward Richman
Richman Chemical Inc.
Roberto Rosenkranz
Roxro Pharma
Ivor Royston
Viracta Therapeutics
William J. Rutter
Synergenics, LLC
George Scangos
Vir Biotechnology
Phillip A. Sharp
Massachusetts Institute of Technology
Jay P. Siegel
Janssen Research & Development
Vincent F. Simmon
Genex
Mark Skaletsky
Fenway Pharmaceuticals
Peter H. Spitz
Chem Systems
A. Wayne Tamarelli
AWT Private Investments
Holden H. Thorp
Washington University
Thomas G. Turi
Covance
J. Craig Venter
J. Craig Venter Institute
Josef von Rickenbach
stet vision
Richard N. Zare
Stanford University